Azienda Sanitaria Locale 2 Lanciano Vasto Chieti

At Azienda Sanitaria Locale 2 Lanciano Vasto Chieti, the Cardiologia Universitaria team is involved in research on cardiovascular diseases, with a focus on preventing major events such as heart attack and stroke. These studies are designed to evaluate new approaches for reducing risk in people with high cardiovascular vulnerability and those living with atrial fibrillation.

• Primary prevention of atherosclerotic cardiovascular disease
• Prevention of stroke or systemic embolism in atrial fibrillation
• Testing new treatments aimed at lowering the risk of serious cardiovascular complications

This area reflects a strong interest in improving long-term heart and circulation health through better prevention strategies and treatment comparisons.

The site is also contributing to research in eye diseases, especially glaucoma, a condition that can gradually damage vision. The clinical trial work here is focused on finding better ways to protect visual function and slow disease progression in patients receiving standard care.

• Glaucoma
• Preserving visual field and limiting vision loss
• Evaluating whether a new eye treatment can improve outcomes over placebo

This research supports earlier and more effective management of chronic vision-threatening disease.

Clinical research in immune system diseases at this hospital includes studies in Behçet's disease, with attention to painful oral ulcers that can significantly affect daily life. The trials are aimed at improving symptom control and testing whether new therapies can offer better relief than placebo.

• Behçet's disease
• Oral ulcers associated with Behçet’s Disease
• Assessing treatment effectiveness for inflammatory symptoms

This field highlights the site’s role in studying inflammatory conditions that require careful, patient-centered treatment options.

The research portfolio includes neoplasms, particularly high risk non-muscle invasive bladder cancer. Trials in this area are exploring whether combining established and newer therapies can improve cancer control and reduce the chance of disease returning or progressing.

• High Risk Non-muscle invasive bladder cancer
• Comparing treatment strategies for better cancer outcomes
• Studying whether adding a new therapy improves response

This work supports ongoing efforts to refine cancer treatment and strengthen disease management for patients at higher risk.

The site is participating in studies of musculoskeletal diseases, including moderate to severe rotator cuff tendinopathy. These trials are focused on easing shoulder pain and improving physical function, with the goal of finding more effective options for people whose symptoms limit movement and daily activities.

• Moderate to severe rotator cuff tendinopathy
• Improving shoulder symptoms and mobility
• Evaluating a potential new treatment against placebo

Overall, this research area centers on better symptom relief and functional recovery in a common and often disabling tendon condition.